PDL BioPharma (PDLI) Reports Q4 Adj EPS of $0.05
Tweet Send to a Friend
PDL BioPharma (Nasdaq: PDLI) reports Q4 EPS of $0.05, 3 cents ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
